|
|
|
Hey, it is CERI Cancer Quiz Day! Write in the comment box below your answer to be considered as the winner shall you answer correctly! Winners and the answer will be announced the NEXT DAY, on Thursdays! Good Luck!  Tip: Watch our video to get the answer. ;)
0 Comments
Here is the correct answer and the winner to our this week's CERI Cancer Quiz. Topic: Cancer markers⚡ CONGRATULATIONS to our winner - YAY! 💪 THANK YOU to all those who have participated. 👍 Also, we would like shout out a big THANK YOU to all of our supporters. Thank you for being here and for all of your support! 🙏 Enjoy and see you all again in our next quiz! 💪 #Empowermentagainstcancer™ #CERICancerQuiz™ #canceredinstitute   Learn more here.
Hey, it is CERI Cancer Quiz Day! Write in the comment box below your answer to be considered as the winner shall you answer correctly! Winners and the answer will be announced the NEXT DAY, on Thursdays! Good Luck!  Tip: Read more here to find the answer.
Here is the correct answer and the winner to our this week's CERI Cancer Quiz. Topic: Cancer in pets⚡ THANK YOU to all those who have participated. 👍 Also, we would like shout out a big THANK YOU to all of our supporters. Thank you for being here and for all of your support! 🙏 Enjoy and see you all again in our next quiz! 💪 #Empowermentagainstcancer™ #CERICancerQuiz™ #canceredinstitute   Hey, it is CERI Cancer Quiz Day! Write in the comment box below your answer (ONE answer per person please) to be considered as the winner shall you answer correctly! Winners and the answer will be announced the NEXT DAY, on Thursdays! Good Luck!  Tip: You can learn more here.
Hi everyone, here is the correct answer and the winner to our this week's CERI Cancer Quiz. Topic: Head and Neck Cancer⚡ THANK YOU to all those who have participated. 👍 Also, we would like shout out a big THANK YOU to all of our supporters. Thank you for being here and for all of your support! 🙏 Enjoy and see you all again in our next quiz! 💪 #Empowermentagainstcancer™ #CERICancerQuiz™ #canceredinstitute  Want to learn more why? Read our article here.  Hey, it is CERI Cancer Quiz Day! Write in the comment box below your answer (ONE answer per person please) to be considered as the winner shall you answer correctly! Winners and the answer will be announced the NEXT DAY, on Thursdays! Good Luck!  Tip: Check out our article.
Hi everyone, here is the correct answer and the winner to our this week's CERI Cancer Quiz. Topic: Inflammation⚡ THANK YOU to all those who have participated. 👍 Also, we would like shout out a big THANK YOU to all of our supporters. Thank you for being here and for all of your support! 🙏 Enjoy and see you all again in our next quiz! 💪 #Empowermentagainstcancer™ #CERICancerQuiz™ #canceredinstitute  To learn more about the correct answer as to why inflammation can cause cancer, read our article here.  Hey, it is CERI Cancer Quiz Day! Write in the comment box below your answer (ONE answer per person please) to be considered as the winner shall you answer correctly! Winners and the answer will be announced the NEXT DAY, on Thursdays! Good Luck!  Tip: Check out our article.
3/18/2022: FDA approved OPDUALAG™ (nivolumab and relatlimab-rmb w, Bristol-Myers Squibb) to treat unresectable or metastatic melanoma. OPDUALAG is a combination of nivolumab, a programmed death receptor-1 (PD-1) blocking antibody, and relatlimab, a lymphocyte activation gene-3 (LAG-3) blocking antibody, indicated for the treatment of adult and pediatric patients 12 years of age or older with unresectable or metastatic melanoma. Recommended Dosage: • Adult patients and pediatric patients 12 years of age or older who weigh at least 40 kg: 480 mg nivolumab and 160 mg relatlimab intravenously every 4 weeks. • Administer OPDUALAG as an intravenous infusion over 30 minutes. Learn more in the FDA label here.  1/25/2022: FDA approved KIMMTRAK® (tebentafusp-tebn, Immunocore) to treat unresectable or metastatic uveal melanoma. KIMMTRAK is a bispecific gp100 peptide-HLA-directed CD3 T cell engager indicated for the treatment of HLA-A*02:01-positive adult patients with unresectable or metastatic uveal melanoma. Recommended dosage: 20 mcg intravenously on Day 1, 30 mcg intravenously on Day 8, 68 mcg intravenously on Day 15, and 68 mcg intravenously once every week there after. Learn more in the FDA label here.  |
|
|
|
|
|
|
|
|
|
|